Fosun Pharma To Acquire India’s Gland Pharma Stake From KKR For $1.26B

Jillian Yue
July 29, 2016 — 10:54 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: acquisition india KKR manufacturing pharmaceutical Private Equity Shanghai

Related News:

A Joint Fund By Allianz Real Estate And Keppel Capital-Linked Fund To Buy Beijing Office

October 16, 2019 — 15:26

Chinese Smartphone Maker Vivo To Invest $559M For Second Plant In India

December 14, 2018 — 14:54

Alibaba-Backed E-Commerce Platform Lazada Names New CEO As Part Of Succession Plan

December 13, 2018 — 19:56

Chinese News App Toutiao Considering Hong Kong IPO

July 10, 2018 — 23:16

Airbus To Develop Nanocomposite Materials For Aircraft Application In China

July 6, 2018 — 13:11

Beijing Government Sets Up $4.6B Fund To Back Core Tech Innovations

June 25, 2018 — 13:48

Chinese Foreign Direct Investment In US Drops 92% In First Half

June 21, 2018 — 10:20

China Launches $15.6B Fund To Support Yangtze River Delta Economic Zone

June 4, 2018 — 12:08

GIC, Warburg Pincus’ Nova Set Up $675M Rental Apartment Platform In China

May 15, 2018 — 10:33

Franchising and Licensing Asia (FLAsia) 2024